Gold(I) complexes with saccharide-based ligands have been extensively studied in recent years, as they have shown significant in vitro cytotoxic activity against many cisplatin-resistant tumor cell lines (Rigobello et al., 2008). Unlike cisplatin, which targets DNA to exert its cytotoxic effect, gold(I) complexes interrupt intracellular protein signaling mechanisms (particularly thioredoxin reductase), leading to cell apoptosis (da Silva Maia, Deflon, & Abram, 2014). The structure of ligands used to synthesize gold(I) complexes has great influence on their biological activity (Yeo et al., 2013). An important factor is the lipophilicity of the ligand, which directly impacts the ability of the complex to penetrate through cell membranes. The insertion of a tertiary phosphine group in some gold(I) complexes (as in auranofin) has consistently resulted in increased biological activity, when compared to their analogous non-phosphorated compounds (Ott et al., 2009).